<!DOCTYPE html>
<html lang="en" data-theme="light">
<head><script src="/livereload.js?mindelay=10&amp;v=2&amp;port=1315&amp;path=livereload" data-no-instant defer></script>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Kamada Ltd. Expands Plasma Collection Capabilities in Texas with New San Antonio Center - Building Texas Show News</title>
    
    
    <meta name="description" content="Kamada Ltd. expands its specialty hyper-immune plasma collection with the opening of a new plasma collection center in San Antonio, Texas. The company aims to receive FDA and EMA approvals for the facility within nine to twelve months. This strategic move is expected to lower raw material costs and strengthen Kamada&#39;s position in the specialty plasma-derived therapeutics market.">
    <meta name="keywords" content="news, breaking news, current events, analysis, journalism">
    <meta name="author" content="Building Texas Show">
    
    
    <meta property="og:title" content="Kamada Ltd. Expands Plasma Collection Capabilities in Texas with New San Antonio Center - Building Texas Show News">
    <meta property="og:description" content="Kamada Ltd. expands its specialty hyper-immune plasma collection with the opening of a new plasma collection center in San Antonio, Texas. The company aims to receive FDA and EMA approvals for the facility within nine to twelve months. This strategic move is expected to lower raw material costs and strengthen Kamada&#39;s position in the specialty plasma-derived therapeutics market.">
    <meta property="og:type" content="article">
    <meta property="og:url" content="http://localhost:1315/posts/2025-06-15-kamada-ltd-expands-plasma-collection-capabilities-in-texas-with-new-san-antonio-center/">
    
    <meta property="og:image" content="https://cdn.newsramp.app/banners/health-wellness-3.jpg">
    
    
    
    <meta name="twitter:card" content="summary_large_image">
    <meta name="twitter:title" content="Kamada Ltd. Expands Plasma Collection Capabilities in Texas with New San Antonio Center - Building Texas Show News">
    <meta name="twitter:description" content="Kamada Ltd. expands its specialty hyper-immune plasma collection with the opening of a new plasma collection center in San Antonio, Texas. The company aims to receive FDA and EMA approvals for the facility within nine to twelve months. This strategic move is expected to lower raw material costs and strengthen Kamada&#39;s position in the specialty plasma-derived therapeutics market.">
    
    
    <link rel="canonical" href="http://localhost:1315/posts/2025-06-15-kamada-ltd-expands-plasma-collection-capabilities-in-texas-with-new-san-antonio-center/">
    
    
    <link href="https://cdn.jsdelivr.net/npm/daisyui@4.12.10/dist/full.min.css" rel="stylesheet" type="text/css" />
    <script src="https://cdn.tailwindcss.com"></script>
    
    
    <style>
         
        @import url('https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap');
        
         
        :root {
          --primary: #0f766e;  
          --primary-content: #ffffff;
          --secondary: #64748b;
          --accent: #dc2626;  
          --neutral: #0f766e;  
          --base-100: #ffffff;
          --base-200: #f8fafc;
          --base-300: #e2e8f0;
          --base-content: #1f2937;
          --teal-600: #0d9488;
          --teal-700: #0f766e;
          --teal-800: #115e59;
        }

         
        [data-theme="light"] {
          --primary: #0f766e;
          --primary-content: #ffffff;
          --secondary: #64748b;
          --accent: #dc2626;
          --neutral: #0f766e;
          --base-100: #ffffff;
          --base-200: #f8fafc;
          --base-300: #e2e8f0;
          --base-content: #1f2937;
          background-color: #ffffff;
          color: #1f2937;
        }

         
        html, body {
          font-family: 'Inter', -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;
          background-color: inherit;
          color: inherit;
          line-height: 1.6;
        }

         
        main {
          background-color: #a5f3fc;
          color: #1f2937;
          min-height: calc(100vh - 200px);
        }

         
        .content-card {
          background: rgba(255, 255, 255, 0.95);
          color: #1f2937;
          border-radius: 8px;
          box-shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.1);
        }

         
        h1, h2, h3, h4, h5, h6 {
          font-weight: 600;
          line-height: 1.3;
        }

         
        .btn-primary {
          background-color: #0f766e;
          border-color: #0f766e;
          color: white;
        }

        .btn-primary:hover {
          background-color: #0d9488;
          border-color: #0d9488;
        }

         
        a {
          color: #0f766e;
          text-decoration: none;
        }

        a:hover {
          color: #0d9488;
        }

         
        .nav-hover:hover {
          background-color: var(--primary) !important;
          color: var(--primary-content) !important;
        }

        .dropdown-content {
          background-color: var(--base-100) !important;
          border: 1px solid var(--base-300) !important;
        }

        .dropdown-item:hover {
          background-color: var(--primary) !important;
          color: var(--primary-content) !important;
        }

        .group:hover .group-hover\:block {
          display: block !important;
        }
    </style>
    
</head>
<body class="min-h-screen bg-base-100">
    
<div class="bg-white border-b border-gray-200">
  <div class="container mx-auto px-4 py-4">
    <div class="flex items-center justify-between">
      
      <a href="/" class="flex items-center">
        <img
          src="https://newswriter.ai/logo.svg"
          alt="Newswriter.ai"
          class="h-8 w-auto"
        />
        <span class="text-sm text-gray-500 ml-3"
          >Let AI Write Your Press Release</span
        >
      </a>

      
      <div class="relative">
        <div class="dropdown dropdown-end">
          <div tabindex="0" role="button" class="btn btn-primary">
            Write My Press Release
            <svg
              class="w-4 h-4 ml-1"
              fill="none"
              stroke="currentColor"
              viewBox="0 0 24 24"
            >
              <path
                stroke-linecap="round"
                stroke-linejoin="round"
                stroke-width="2"
                d="M19 9l-7 7-7-7"
              ></path>
            </svg>
          </div>
          <ul
            tabindex="0"
            class="dropdown-content menu bg-base-100 rounded-box z-[1] w-52 p-2 shadow"
          >
            <li><a href="#" class="text-sm">Write New Press Release</a></li>
            <li><a href="#" class="text-sm">Improve Existing Release</a></li>
            <li><a href="#" class="text-sm">View Examples</a></li>
            <li><a href="#" class="text-sm">Pricing</a></li>
          </ul>
        </div>
      </div>
    </div>
  </div>
</div>

    
    <main>
        

<div class="container mx-auto px-4 py-8">
  <div class="max-w-4xl mx-auto">
    
    <div class="text-sm mb-6">
      <a href="/" class="text-primary hover:underline">Home</a>
      <span class="text-gray-500 mx-2"> / </span>
      <span class="text-gray-500">Article</span>
    </div>

    
    <div class="mb-8">
      <h1
        class="text-4xl md:text-5xl font-bold text-base-content leading-tight mb-6"
      >
        Kamada Ltd. Expands Plasma Collection Capabilities in Texas with New San Antonio Center
      </h1>

      
      <div class="border-b border-gray-200 pb-6 mb-8">
        <div class="flex items-center text-sm mb-4">
          <span class="text-primary font-semibold"> Building Texas Show News </span>
          <span class="text-gray-400 mx-2"> • </span>
          <span class="text-base-content opacity-70">
            June 15, 2025
          </span>
        </div>

        
        
        <a
          href="https://www.newmediawire.com/news/kamada-expects-third-plasma-collection-site-to-support-its-hyper-immune-plasma-needs-and-add-up-to-10m-in-annual-revenue-at-full-capacity-7080482"
          target="_blank"
          class="inline-flex items-center text-primary hover:text-primary-focus underline font-medium"
        >
          Read Original Article →
        </a>
        
      </div>
    </div>

    
    
    <div class="mb-8">
      <img
        src="https://cdn.newsramp.app/banners/health-wellness-3.jpg"
        alt="Kamada Ltd. Expands Plasma Collection Capabilities in Texas with New San Antonio Center"
        class="w-full h-96 object-cover rounded-lg shadow-lg mb-8"
      />
    </div>
    

    
    
    <div class="bg-base-200 p-6 rounded-lg mb-8">
      <h2 class="text-2xl font-bold text-base-content mb-4">Summary</h2>
      <div
        class="text-lg leading-relaxed mb-8 prose prose-lg max-w-none"
        style="color: var(--base-content)"
      >
        <p>Kamada Ltd., a global biopharmaceutical company, is expanding its specialty hyper-immune plasma collection with the opening of a new plasma collection center in San Antonio, Texas. This facility will support as many as 50 donor beds and is projected to collect up to 50,000 liters annually, adding to Kamada's supply of specialty plasma products. The company aims to receive approvals from the FDA and EMA within nine to twelve months of submitting applications.</p>
      </div>
    </div>
    

    
    <div class="mb-12">
      <h2 class="text-2xl font-bold text-base-content mb-6">Full Article</h2>
      <div
        class="prose prose-lg max-w-none leading-relaxed"
        style="color: var(--base-content)"
      >
        <div class="space-y-4">
          <p class='mb-4'><p>Kamada Ltd., a leading global biopharmaceutical company, has taken a significant step forward in its mission to address rare and underserved medical conditions by opening a new plasma collection center in San Antonio, Texas. This 11,100-square-foot facility marks the company's third such center in the state, following recent openings in Houston and Beaumont. With the capacity to accommodate up to 50 donor beds, the center is expected to collect approximately 50,000 liters of plasma annually, contributing significantly to the supply of hyper-immune plasma used in critical medical treatments.</p><p>The strategic expansion is not just a milestone for Kamada but also a boon for the medical community and patients relying on plasma-derived therapeutics. Hyper-immune plasma, known for its high concentrations of specific antibodies, plays a pivotal role in reducing infection risks and mitigating disease severity, particularly for conditions like rabies exposure, lung diseases, and infectious complications in immunocompromised patients. The San Antonio center, once fully operational and upon receiving necessary approvals from the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), is projected to generate between $8 million and $10 million in annual sales of normal source plasma.</p><p>Amir London, CEO of Kamada, highlighted the dual benefits of this expansion: reducing dependency on third-party suppliers and improving production costs. This move not only strengthens Kamada's position in the specialty plasma market but also ensures a more reliable supply chain for plasma-derived therapeutics, potentially benefiting industry peers and patients worldwide. With six FDA-approved products already in its portfolio, Kamada's continued investment in Texas underscores the state's growing importance as a hub for biopharmaceutical innovation and healthcare solutions.</p><p>The opening of the San Antonio plasma collection center is a testament to Kamada's commitment to addressing complex medical needs through innovation and strategic growth. As the company expands its internal plasma collection capabilities, it sets a precedent for how biopharmaceutical companies can enhance their operational efficiency while making a tangible impact on global health challenges.</p></p>
        </div>
      </div>
    </div>

    
    
    <div class="bg-base-200 p-4 rounded-lg mb-8 text-sm text-gray-600">
      
      <p>Article ID: 79844</p>
       
      <p>Feed Item ID: 13085</p>
      
    </div>
    

    
    <div class="text-center">
      <a href="/" class="btn btn-outline btn-lg">← Back to Home</a>
    </div>
  </div>
</div>

    </main>
    
    
<footer class="bg-teal-700 text-white">
  <div class="container mx-auto px-4 py-6">
    <div class="flex flex-col md:flex-row justify-between items-center gap-4">
      <div class="flex items-center gap-4">
        <p class="text-sm">
          Newswriter.ai © 2025 All Rights Reserved
        </p>
        <a href="#" class="text-sm hover:text-teal-200 transition-colors"
          >Privacy Policy</a
        >
        <a href="#" class="text-sm hover:text-teal-200 transition-colors"
          >Terms of Service</a
        >
      </div>

      
      <div class="flex items-center">
        <div
          class="bg-white text-black px-3 py-1 rounded flex items-center gap-2"
        >
          <div class="border-2 border-black rounded px-2 py-1">
            <span class="font-bold text-xs">AI<br />TS</span>
          </div>
          <div class="text-xs">
            <div class="font-semibold">Verified Tool on</div>
            <div class="font-bold">AI Tech Suite</div>
          </div>
          <div class="text-lg">✓</div>
        </div>
      </div>
    </div>
  </div>
</footer>

</body>
</html>
